Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hildner

Showing results (251-260 of 255) with videos related to

Pageof 26
Sort By:
You have reached the last page of results.This site can display upto 255 results.
Nature Communications|February 19, 2021
Interleukin-3 is a predictive marker for severity and outcome during SARS-CoV-2 infectionsAlan Bénard, Anne Jacobsen, Maximilian Brunner, et al.
Nature Medicine|February 6, 2019
Publisher Correction: ApoE attenuates unresolvable inflammation by complex formation with activated C1qChangjun Yin, Susanne Ackermann, Zhe Ma, et al.
Gut|April 29, 2025
Integrated multimodel analysis of intestinal inflammation exposes key molecular features of preclinical and clinical IBDMiguel Gonzalez-Acera, Jay V Patankar, Lena Erkert, et al.
Nature Communications|October 20, 2025
The microbial metabolite desaminotyrosine protects against graft-versus-host disease via mTORC1 and STING-dependent intestinal regenerationSascha Göttert, Erik Thiele Orberg, Kaiji Fan, et al.
JAMA Neurology|January 20, 2026
Virus-Specific T Cells and Response to Checkpoint Inhibitors in Progressive Multifocal LeukoencephalopathyNora Möhn, Lea Grote-Levi, Agnes Bonifacius, et al.
Pageof 26

Showing results (251-260 of 255) with videos related to

Sort By:
Pageof 26
You have reached the last page of results.This site can display upto 255 results.
Nature Communications|February 19, 2021
Interleukin-3 is a predictive marker for severity and outcome during SARS-CoV-2 infectionsAlan Bénard, Anne Jacobsen, Maximilian Brunner, et al.
Nature Medicine|February 6, 2019
Publisher Correction: ApoE attenuates unresolvable inflammation by complex formation with activated C1qChangjun Yin, Susanne Ackermann, Zhe Ma, et al.
Gut|April 29, 2025
Integrated multimodel analysis of intestinal inflammation exposes key molecular features of preclinical and clinical IBDMiguel Gonzalez-Acera, Jay V Patankar, Lena Erkert, et al.
Nature Communications|October 20, 2025
The microbial metabolite desaminotyrosine protects against graft-versus-host disease via mTORC1 and STING-dependent intestinal regenerationSascha Göttert, Erik Thiele Orberg, Kaiji Fan, et al.
JAMA Neurology|January 20, 2026
Virus-Specific T Cells and Response to Checkpoint Inhibitors in Progressive Multifocal LeukoencephalopathyNora Möhn, Lea Grote-Levi, Agnes Bonifacius, et al.
Pageof 26